Mirum Pharmaceuticals (STU:08D) Institutional Ownership: 70.39% (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:08D Mirum Pharmaceuticals Inc STU:08D
52 GF Score
Price €91.94
GF Value €67.91
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Mirum Pharmaceuticals Institutional Ownership?

Mirum Pharmaceuticals STU:08D -5.61% 52 Institutional Ownership is 70.39% as of Aug. 03, 2026. GuruFocus rates STU:08D with a GF Score™ of 52/100 and a GF Value™ of €67.91 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mirum Pharmaceuticals's institutional ownership is 70.39%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mirum Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mirum Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 76.24%.

Mirum Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Mirum Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mirum Pharmaceuticals Institutional Ownership Chart

Mirum Pharmaceuticals Historical Data

The historical data trend for Mirum Pharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 56.32 56.16 56.61 59.04 60.48 60.72 66.93 60.08 62.77 70.39
STU:08D
52GF Score
Mirum Pharmaceuticals Inc STU:08D
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mirum Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 70.39% mean?
Mirum Pharmaceuticals (STU:08D) has a Institutional Ownership of 70.39% as of Aug. 03, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Mirum Pharmaceuticals and its competitors.
Is Mirum Pharmaceuticals' Institutional Ownership too high?
Mirum Pharmaceuticals' current Institutional Ownership is 70.39%. Overall, Mirum Pharmaceuticals has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mirum Pharmaceuticals' Institutional Ownership compare to COGT and RYTM?
Mirum Pharmaceuticals' Institutional Ownership of 70.39% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Mirum Pharmaceuticals and its competitors. Mirum Pharmaceuticals's current Institutional Ownership is 70.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mirum Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Mirum Pharmaceuticals (STU:08D) is currently considered Significantly Overvalued. The stock's GF Value™ is €67.91, compared to a current price of €91.94 — trading 35.4% above its estimated fair value. The current Institutional Ownership is 70.39%. Mirum Pharmaceuticals' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Mirum Pharmaceuticals (STU:08D), the current Institutional Ownership is 70.39% as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mirum Pharmaceuticals (STU:08D) Overvalued in 2026?

Based on GuruFocus' analysis, Mirum Pharmaceuticals stock appears to be overvalued. The current stock price of €91.94 is trading 35.4% above its estimated GF Value™ of €67.91. GuruFocus considers Mirum Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for STU:08D:

  • Institutional Ownership: 70.39%
  • GF Value™: €67.91 vs. price of €91.94 (35.4% above fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the STU:08D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mirum Pharmaceuticals Business Description

Other Exchanges MIRM:USA
Address 989 East Hillsdale Boulevard, Suite 300, Foster City, CA, USA, 94404
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
52GF Score

Get the complete analysis for STU:08D

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€91.94
Price
€67.91
GF Value